UFF
TGTX icon

USA Financial Formulas’s TG Therapeutics TGTX Stock Holding History

USA Financial Formulas’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Buy
+1,344
New +$55K 0.01% 221
2025
Q3 		– Sell
-1,497
Closed -$53.9K – 327
2025
Q2 		$53.9K Buy
1,497
+61
+4% +$2.27K 0.01% 205
2025
Q1 		$56.6K Buy
+1,436
New +$48.3K 0.01% 194

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

USA Financial Formulas's TGTX Position: Q2 2026 in Review

USA Financial Formulas opened a new position in TG Therapeutics (TGTX) in Q2 2026: 1,344 shares worth $73.8K. The stake represents 0.01% of the portfolio and ranks #221 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in TGTX as recently as Q2 2025.

USA Financial Formulas first reported a position in TGTX in Q1 2025 and has held it in 3 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • USA Financial Formulas held 1,344 shares of TG Therapeutics worth $73.8K as of Q2 2026.
  • TG Therapeutics was a new USA Financial Formulas position in Q2 2026.
  • TG Therapeutics made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #221 holding.
  • USA Financial Formulas first reported a position in TG Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.